Key Takeaway

ZHANSHENG WEIGE CHAOYUE XILISHI tablets, 2000 mg, 6-count bottle, labeling is in foreign language by A&H Focal Inc. was recalled on March 7, 2017. The hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfu...

FDA Drug Class I Terminated

ZHANSHENG WEIGE CHAOYUE XILISHI tablets, 2000 mg, 6-count bottle, labeling is in foreign language

Recalled: March 7, 2017 ~unknown units affected D-0562-2018

Description

ZHANSHENG WEIGE CHAOYUE XILISHI tablets, 2000 mg, 6-count bottle, labeling is in foreign language

Hazard / Reason

Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.

Class I: Dangerous or defective product that could cause serious health problems or death.

Class I is the most serious recall classification used by the FDA, indicating a reasonable probability of serious health consequences or death.

Products Affected

ZHANSHENG WEIGE CHAOYUE XILISHI tablets, 2000 mg, 6-count bottle, labeling is in foreign language

Drugs

Company Information

A&H Focal Inc.

Staten Island, NY, United States

View all 21 recalls by A&H Focal Inc. →

Distribution

NY and NJ through six retail stores named "Asian Food Markets"

Related Recalls

FDA Drug Class I

LANG YI HAO CHAONONGSUOPIAN tablets, 500 mg, 8-count bottle, labeling is in foreign language

March 7, 2017
FDA Drug Class I

HU HU SHENG WEI capsules, 3000 mg, 2-count bottle, labeling is in foreign language

March 7, 2017
FDA Drug Class II

Ye Lang Shen capsules, 5000 mg, 8-count bottle, labeling is in foreign language

March 7, 2017
FDA Drug Class III

Indian God Lotion Spray Bottle, labeling is in foreign language

March 7, 2017
FDA Drug Class I

GERMANY BLACK GOLD tablets, 2800 mg, 8-count bottle, labeling is in foreign language

March 7, 2017
FDA Drug Class I

Zhonghua Niubian tablets, 2000mg, 6-count bottle, labeling is in foreign language

March 7, 2017

Frequently Asked Questions

Is this recall still active?

Check the status badge at the top of this page. "Ongoing" means the recall is still active and you should follow the remedy instructions. "Completed" or "Terminated" means the recall process has concluded, though the safety issue remains relevant for any unrepaired products.

How do I check if my product is affected?

Compare the model number, lot code, serial number, or date range listed in the recall notice with the information on your product's label or packaging. For vehicles, check your VIN at NHTSA.gov/Recalls.

What remedy is available for this recall?

Check the remedy section above or contact the manufacturer directly for current remedy options.

Where can I find the original recall notice?

This recall was issued by FDA Drug. Visit the agency's official website for the original notice.

Data sourced from FDA Drug Enforcement. Recall information may not reflect the most current status. RecallDex is not affiliated with any US government agency. Contact the manufacturer or relevant agency for the latest information.